The USPTO is seeking comments from the public regarding the impact of patent eligibility jurisprudence in the United States since the Supreme Court’s 2016 decisions in Mayo and Alice and subsequent Federal Circuit decisions applying the Supreme Court’s legal framework. Read more
On May 18, the USPTO published a Notice of Proposed Rulemaking (NPRM) to implement changes to trademark rules of practice authorized by the Trademark Modernization Act (TMA) of 2020. Read more
On May 18, the USPTO published a Notice of Proposed Rulemaking (NPRM) to implement changes to trademark rules of practice authorized by the Trademark Modernization Act (TMA) of 2020. Read more
Santa Clara University School of Law is conducting a study to identify, understand, and provide actionable advice about the best practices for attracting and including diverse inventors in the invention and patenting process. Read more
A major piece of copyright legislation, the Copyright Alternative in Small-Claims Enforcement Act (CASE Act), was tucked into the omnibus spending and COVID-19 relief bill passed by Congress on December 21, 2020. Read more
As of this writing, the United States Food and Drug Administration (“FDA”) has approved GW Pharma’s CBD drug Epidiolex for treating profound refractory pediatric epilepsy syndromes (Dravet syndrome and Lennox Gastaut syndrome) as well as for treating seizures associated with tuberous sclerosis complex (TSC) in patients one year of age or older. Read more
On September 21, 2020 the Copyright Office announced that Librarian of Congress Carla Hayden had appointed Shira Perlmutter as Register of Copyrights and director of the U.S. Copyright Office. Perlmutter will step into the role in late October and will assume leadership of the organization during its 150th anniversary year. Read more